Cheryl Cho-Phan
Academic Appointments
- Clinical Assistant Professor, Medicine - Oncology
Key Documents
Contact Information
-
Clinical Offices
GI Oncology Clinic 875 Blake Wilbur Drive, Clinic F Stanford, CA 94305 Tel Work (650) 498-6000 Fax (650) 736-4167
- Academic Offices
Personal Information Tel (650) 498-6000Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Cancer> GI Oncology
- Gastrointestinal Cancers
- Medical Oncology
- Oncology (Cancer)
Professional Education
| Residency: | Oregon Health Sciences Univ Hospital OR (1999) |
| Fellowship: | Stanford University School of Medicine CA (2002) |
| Medical Education: | Georgetown University Hospital DC (1996) |
Industry Relationships
Stanford is committed to ethical and transparent interactions with our industrial and other commercial partners. It is our policy to disclose payments (exclusive of travel support) from, and/or equity in, companies or other commercial entities to Stanford faculty of $5,000 or more in total value, as well as any equity in a privately held company, when the faculty member also has institutional responsibilities related to his or her interactions with the company. View Full Information
Scientific Focus
Clinical Trials
- Not Recruiting Combination SBRT (Stereotactic Body Radiotherapy) With TACE (Transarterial Chemoembolization) for Unresectable Hepatocellular Carcinoma
- Recruiting Perfusion CT as a Predictor of Treatment Response in Patients With Hepatic Malignancies
- Not Recruiting Transarterial Chemoembolization vs CyberKnife for Recurrent Hepatocellular Carcinoma
- Recruiting Perfusion CT as a Predictor of Treatment Response in Patients With Rectal Cancer
- Not Recruiting Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCC
Publications
- A phase II study of gefitinib, 5-fluorouracil, leucovorin, and oxaliplatin in previously untreated patients with metastatic colorectal cancer. Clin Cancer Res. 2008; (21): 7074-9
- Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys. 2004; (4): 1017-21
- Phase I and pharmacokinetic study of BMS-188797, a new taxane analog, administered on a weekly schedule in patients with advanced malignancies. Clin Cancer Res. 2003; (14): 5187-94
- Phase II trial of preoperative 3D conformal radiotherapy, protracted venous infusion 5-fluorouracil, and weekly CPT-11, followed by surgery for ultrasound-staged T3 rectal cancer. Int J Radiat Oncol Biol Phys. 2003; (1): 132-7
Help
Trial Administration